Promethiol syrup should not be used in pediatric patients less than 2 years of age because of the potential for fatal respiratory depression.
To be used with caution and doctor's/pharmacist's advice in children 2 to 6 years of age.
Productive coughs, which represent a fundamental element in the bronchial and pulmonary defense, should not be suppressed.
It is irrational to combine an expectorant or a mucolytic with this antitussive medicine.
Before prescribing an antitussive, it is advisable to ensure that the underlying causes of the cough which required specific treatment, have been investigated.
If the cough does not respond to the antitussive treatment administered at the normal dosage, the dosage should not be increased but the clinical situation should be reassessed.
Mucolytic agents may induce severe bronchial congestion in infants. Their bronchial mucus drainage capacities are limited due to the physiological characteristics of their bronchial tree. Mucolytics should therefore not be used in infants.
Treatment should be re-evaluated if symptoms or the disease persist or worsen.
This medicinal product contains sucrose. It is not recommended for use in patients with fructose intolerance, glucose or galactose malabsorption syndrome or sucrase-isomaltase deficiency.